Saxagliptin and Dapagliflozin

Therapeutic indications

Saxagliptin and Dapagliflozin is indicated for:

Diabetes mellitus type 2

Population group: only adults (18 years old or older)

The fixed dose combination of saxagliptin and dapagliflozin, is indicated in adults aged 18 years and older with type 2 diabetes mellitus:

  • to improve glycaemic control when metformin and/or sulphonylurea (SU) and one of the monocomponents of saxagliptin/dapagliflozin do not provide adequate glycaemic control,
  • when already being treated with the free combination of dapagliflozin and saxagliptin.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Saxagliptin and Dapagliflozin is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: QTERN Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈